| Literature DB >> 26777972 |
Ioannis Rotas1, Giovanni Cito2, Igor Letovanec3, Michel Christodoulou2, Jean Y Perentes4.
Abstract
Hypertrophic osteoarthrpathy (HO) is a rare paraneoplasic syndrome associated with non-small cell lung cancer (NSCLC). The pathophysiology of HO is unknown but was recently related to enhanced levels of urine prostaglandin E2 (PGE2). Here, we report the case of a patient that presented HO in association with a resectable left upper lobe NSCLC. Following surgery and adjuvant chemotherapy, HO resolved and did not recur with development of a brain metastasis 1 year later. Interestingly, tumor cyclooxygenase-2, an enzyme responsible the synthesis of PGE2, was expressed in the primary tumor but not in the resected metastasis.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26777972 DOI: 10.1016/j.athoracsur.2015.09.023
Source DB: PubMed Journal: Ann Thorac Surg ISSN: 0003-4975 Impact factor: 4.330